Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 50,000 shares of the stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $10.33, for a total transaction of $516,500.00. Following the completion of the sale, the chief executive officer now directly owns 9,907,691 shares of the company’s stock, valued at approximately $102,346,448.03. This trade represents a 0.50 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
K Charles Janac also recently made the following trade(s):
- On Monday, January 6th, K Charles Janac sold 8,432 shares of Arteris stock. The shares were sold at an average price of $12.34, for a total value of $104,050.88.
- On Thursday, January 2nd, K Charles Janac sold 6,256 shares of Arteris stock. The stock was sold at an average price of $11.41, for a total value of $71,380.96.
- On Monday, December 30th, K Charles Janac sold 58,212 shares of Arteris stock. The shares were sold at an average price of $10.33, for a total value of $601,329.96.
- On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The stock was sold at an average price of $10.42, for a total transaction of $631,285.28.
- On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total value of $141,941.80.
- On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total transaction of $180,702.72.
- On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The shares were sold at an average price of $8.58, for a total transaction of $10,656.36.
Arteris Price Performance
Shares of NASDAQ AIP opened at $9.74 on Friday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The company has a market cap of $391.35 million, a price-to-earnings ratio of -10.15 and a beta of 1.18. The stock’s 50-day moving average is $10.40 and its two-hundred day moving average is $8.60. Arteris, Inc. has a 1-year low of $5.76 and a 1-year high of $12.64.
Analyst Ratings Changes
View Our Latest Analysis on Arteris
Hedge Funds Weigh In On Arteris
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. US Bancorp DE purchased a new position in Arteris in the third quarter worth approximately $34,000. R Squared Ltd purchased a new stake in shares of Arteris in the 4th quarter valued at approximately $64,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Arteris in the 2nd quarter valued at $86,000. Algert Global LLC purchased a new stake in shares of Arteris during the 2nd quarter worth $115,000. Finally, MetLife Investment Management LLC grew its stake in shares of Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after purchasing an additional 9,551 shares in the last quarter. 64.36% of the stock is owned by institutional investors and hedge funds.
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More
- Five stocks we like better than Arteris
- How Can Investors Benefit From After-Hours Trading
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- CD Calculator: Certificate of Deposit Calculator
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Dividend Capture Strategy: What You Need to Know
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.